OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation
Jae‐Ho Jeong, Dong Hoon Lee, Juhyun Song
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112933-112933
Open Access | Times Cited: 25

Showing 25 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 219

HMGB1 mediates synaptic loss and cognitive impairment in an animal model of sepsis-associated encephalopathy
Xiaoyu Yin, Xiaohui Tang, Shi-Xu Wang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 60

Effects of Diabetes Mellitus-Related Dysglycemia on the Functions of Blood–Brain Barrier and the Risk of Dementia
Mateusz Wątroba, Anna D. Grabowska, Dariusz Szukiewicz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10069-10069
Open Access | Times Cited: 26

Accumulation of advanced oxidative protein products exacerbate satellite glial cells activation and neuropathic pain
Chen Tu, Shicheng Wang, Min Dai, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1

Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction
Mingyang Sun, Wan‐Ming Chen, Szu‐Yuan Wu, et al.
Brain (2023) Vol. 147, Iss. 4, pp. 1474-1482
Closed Access | Times Cited: 18

Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11450-11450
Open Access | Times Cited: 17

Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program
Kailu Wang, Shi Zhao, Kam-Pui Lee, et al.
JAMA Network Open (2024) Vol. 7, Iss. 2, pp. e2355733-e2355733
Open Access | Times Cited: 7

Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration
Jannis Kountouras, Marina Boziki, Evangelos Kazakos, et al.
Neurochemistry International (2024) Vol. 175, pp. 105724-105724
Closed Access | Times Cited: 7

Type 2 Diabetes and Cognitive Decline: A Neurovascular Perspective
Arbind Kumar Choudhary
Chronicle of Diabetes Research and Practice (2025) Vol. 4, Iss. 1, pp. 31-41
Closed Access

The prospect and underlying mechanisms of Chinese medicine in treating periodontitis
Aili Xing, Feng Wang, Jinzhong Liu, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 3, pp. 269-285
Closed Access

Investigation of N-Glycan Functions in Receptor for Advanced Glycation End Products V Domain through Chemical Glycoprotein Synthesis
Weidong Dong, Xingyue Yang, Xinyu Li, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 27, pp. 18270-18280
Closed Access | Times Cited: 2

The Role of Glucose Concentration and Resveratrol in Modulating Neuroinflammatory Cytokines: Insights from an In Vitro Blood–Brain Barrier Model
Justyna Komorowska, Mateusz Wątroba, Małgorzata Bednarzak, et al.
Medical Science Monitor (2023) Vol. 29
Open Access | Times Cited: 6

The Effectiveness of Antidiabetic Drugs in Treating Dementia: A Peek into Pharmacological and Pharmacokinetic Properties
Jiro Ogura, Hiroaki Yamaguchi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6542-6542
Open Access | Times Cited: 8

Immunological Imbalances Associated with Epileptic Seizures in Type 2 Diabetes Mellitus
Wendy N. Phoswa, Kabelo Mokgalaboni
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 732-732
Open Access | Times Cited: 4

Binding of RAGE and RIPK1 induces cognitive deficits in chronic hyperglycemia‐derived neuroinflammation
Xiaoyan Zhou, Yandong Zhu, Lin Gao, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 3
Open Access | Times Cited: 4

Chemokine CX3CL1 (Fractalkine) Signaling and Diabetic Encephalopathy
Mateusz Wątroba, Anna D. Grabowska, Dariusz Szukiewicz
(2024)
Open Access | Times Cited: 1

Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic target
Saswati Sarkar
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 1

Targeting HMGB1 and Its Interaction with Receptors: Challenges and Future Directions
Pingping Shen, Libang Zhang, Xuewa Jiang, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1

Repeated low-intensity noise exposure exacerbates age-related hearing loss via RAGE signaling pathway
Jianbin Sun, Na Sai, Tong Zhang, et al.
Neurobiology of Disease (2024), pp. 106768-106768
Open Access | Times Cited: 1

Cross-Talk and Subset Control of Microglia and Associated Myeloid Cells in Neurological Disorders
Jatia Mills, Liliana Ladner, Eman Soliman, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3364-3364
Open Access | Times Cited: 5

Chemokine CX3CL1 (Fractalkine) Signaling and Diabetic Encephalopathy
Mateusz Wątroba, Anna D. Grabowska, Dariusz Szukiewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7527-7527
Open Access

Cucurbitacin E Modulates the PI3K/AKT Pathway and Ameliorate Prefrontal Cortex Pathology in Streptozocin-induced Diabetic Rats
Taiwo Adekemi Abayomi, Omolayo Olaniyan, Olorunfemi Tokunbo, et al.
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top